Townsquare Capital LLC Bio N Tech Se Transaction History

Townsquare Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$126.25 - $231.85 $162,862 - $299,086	-1,290 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$216.64 - $362.52 $50,477 - $84,467	-233 Reduced 15.3%	1,290 $333,000
Q3 2021 Nov 15, 2021	SELL	$205.93 - $447.23 $189,661 - $411,898	-921 Reduced 37.68%	1,523 $416,000
Q2 2021 Aug 16, 2021	SELL	$113.32 - $241.49 $2,379 - $5,071	-21 Reduced 0.85%	2,444 $522,000
Q1 2021 May 17, 2021	BUY	$85.73 - $119.5 $211,324 - $294,567	2,465 New	2,465 $269,000

357

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28.8B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Townsquare Capital LLC with notifications on news.